A single dose of neuron-binding human monoclonal antibody improves spontaneous activity in a murine model of demyelination
about
Applications of SPR for the characterization of molecules important in the pathogenesis and treatment of neurodegenerative diseasesNeed for a paradigm shift in therapeutic approaches to CNS injuryAntibody-Mediated Oligodendrocyte Remyelination Promotes Axon Health in Progressive Demyelinating DiseaseA single dose of a neuron-binding human monoclonal antibody improves brainstem NAA concentrations, a biomarker for density of spinal cord axons, in a model of progressive multiple sclerosis.Abbreviated exposure to hypoxia is sufficient to induce CNS dysmyelination, modulate spinal motor neuron composition, and impair motor development in neonatal miceA natural human IgM that binds to gangliosides is therapeutic in murine models of amyotrophic lateral sclerosis.Polysialic acid as an antigen for monoclonal antibody HIgM12 to treat multiple sclerosis and other neurodegenerative disorders.Therapeutics to promote CNS repair: a natural human neuron-binding IgM regulates membrane-raft dynamics and improves motility in a mouse model of multiple sclerosis.A monoclonal natural human IgM protects axons in the absence of remyelinationRecent Advances in Monoclonal Antibody Therapies for Multiple Sclerosis.Antibody Binding Specificity for Kappa (Vκ) Light Chain-containing Human (IgM) Antibodies: Polysialic Acid (PSA) Attached to NCAM as a Case Study.Concomitant Use of Neuroprotective Drugs in Neuro Rehabilitation of Multiple Sclerosis.CD8(+) T cells in multiple sclerosis.Gut dysbiosis and neuroimmune responses to brain infection with Theiler's murine encephalomyelitis virus.A human anti-polysialic acid antibody as a potential treatment to improve function in multiple sclerosis patients.Therapeutic potential of extracellular vesicles derived from human mesenchymal stem cells in a model of progressive multiple sclerosis
P2860
Q26860077-6ABA340F-3974-4843-A751-ADE599644FE5Q27025042-953D94B8-5F74-49C5-B025-4D30F4D077BDQ28080515-20A13020-D604-4D6A-9456-8FB663A15081Q35564304-6AD813BF-1F4E-49BF-9BE6-E96144C47C6DQ35644564-1480151D-F586-4488-9798-79A806133DA2Q35923499-9DBAE76B-2D9D-4798-9157-2163312F0C2BQ35940683-F4C44F9F-0850-4C5D-91DB-D825D7F8D176Q36542427-68AEC4D2-265F-4A38-BD7E-01E88F32AD0EQ36851038-631F6C8B-2BEC-4576-BF4A-754E9E9EA0E0Q37019872-30D1119B-0929-4290-94D2-B458EFCADC96Q37194202-51776E4F-5132-4179-BE09-469785941765Q37221452-84C62BFB-2FE6-4C92-A47D-7E7DB9DFC491Q37591260-E0A24BAD-5FE3-4F34-80B4-6C0F157036F0Q37698703-96B7391F-FE67-4014-A26B-8960DC84EAA6Q38406595-0B12D356-C83B-44FD-BBEB-1D70AC2EEC37Q58720580-AA548101-72FA-4AB5-B039-29A1582CA742
P2860
A single dose of neuron-binding human monoclonal antibody improves spontaneous activity in a murine model of demyelination
description
2011 nî lūn-bûn
@nan
2011 թուականին հրատարակուած գիտական յօդուած
@hyw
2011 թվականին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
A single dose of neuron-bindin ...... murine model of demyelination
@ast
A single dose of neuron-bindin ...... murine model of demyelination
@en
A single dose of neuron-bindin ...... murine model of demyelination
@nl
type
label
A single dose of neuron-bindin ...... murine model of demyelination
@ast
A single dose of neuron-bindin ...... murine model of demyelination
@en
A single dose of neuron-bindin ...... murine model of demyelination
@nl
prefLabel
A single dose of neuron-bindin ...... murine model of demyelination
@ast
A single dose of neuron-bindin ...... murine model of demyelination
@en
A single dose of neuron-bindin ...... murine model of demyelination
@nl
P2093
P2860
P3181
P1433
P1476
A single dose of neuron-bindin ...... murine model of demyelination
@en
P2093
Aleksandar Denic
Arthur E Warrington
Istvan Pirko
Larry R Pease
Slobodan I Macura
P2860
P304
P3181
P356
10.1371/JOURNAL.PONE.0026001
P407
P577
2011-01-01T00:00:00Z